Von Eschenbach resigning from National Cancer Institute
Recently the acting FDA commissioner Andrews von Eschenbach said he would resign from his position as director of the National Cancer Institute. He had come under fire from various quarters by those who felt that both agencies need a full time director and that one person couldn’t do justice to both. I tend to agree and am cautiously optimistic about the development. The FDA definitely needs a full time director and someone who is going to be around for a while to set the vision for the agency. His approval by the Senate will most likely come under fire due to the political uproar over the Plan B emergency contraceptive and the FDA’s decision not to decide. The FDA told Duramed they need more time to make a decision regarding Plan B being available over the counter.
Technorati Tags: FDA
Related Posts:
Bookmark it with:
| 
del.icio.us
| 
Digg it
| 
Furl
| 
Simpy
| 
Spurl
| 
My Yahoo!
|
